Finance

Lists
Why is MRKR down 3,75%?
Dive Deeper
MRKR:NASDAQ
Marker Therapeutics Inc
0,89 US$
-3,75%
(-0,035) 1D
14 ოქტ, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MRKR...
Open
0,92 US$
High
0,95 US$
Low
0,89 US$
Mkt. cap
14,92 მლნ.
Avg. vol.
77,12 ათ.
Volume
0,00
52-wk high
2,46 US$
52-wk low
0,84 US$
EPS
-0,47 US$
Beta
1,53
Shares outstanding
16,67 მლნ.
No. of employees
5
Open
0,92 US$
High
0,95 US$
Low
0,89 US$
Mkt. cap
14,92 მლნ.
Avg. vol.
77,12 ათ.
Volume
0,00
52-wk high
2,46 US$
52-wk low
0,84 US$
EPS
-0,47 US$
Beta
1,53
Shares outstanding
16,67 მლნ.
No. of employees
5
News stories
From web sources and news partners
About Marker Therapeutics Inc
CEO-
Employees5
Founded1992
Headquartersჰიუსტონი, ტეხასი, ამერიკის შეერთებული შტატები
Sector-
Analyst ratings
Based on 2 analysts giving stock ratings to MRKR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for MRKR in the last 3 months.
Highest
Current 0,89 US$
10,00 US$ (+1 023,34%)
Average
9,00 US$ (+911,01%)
Lowest
8,00 US$ (+798,67%)
Analyst
Recommendation
Action
Price target
Projected
Date
Patrick Trucchio
H.C. Wainwright
Buy
Maintained
10,00 US$
+1 023,3%
09/21/2026
John Newman
Canaccord Genuity
Buy
Maintained
8,00 US$
+798,7%
08/17/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
1,23 მლნ.
1,10 მლნ.
751,69 ათ.
681,58 ათ.
Cost of goods sold
2,35 მლნ.
2,14 მლნ.
2,84 მლნ.
1,48 მლნ.
Cost of revenue
2,35 მლნ.
2,14 მლნ.
2,84 მლნ.
1,48 მლნ.
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,02 მლნ.
846,61 ათ.
1,23 მლნ.
1,14 მლნ.
Operating expense
1,02 მლნ.
846,61 ათ.
1,23 მლნ.
1,14 მლნ.
Total operating expenses
3,37 მლნ.
2,99 მლნ.
4,07 მლნ.
2,62 მლნ.
Operating income
-2,14 მლნ.
-1,88 მლნ.
-4,07 მლნ.
-2,62 მლნ.
Other non operating income
-
-
760,37 ათ.
681,58 ათ.
EBT including unusual items
-2,00 მლნ.
-1,72 მლნ.
-3,18 მლნ.
-1,83 მლნ.
EBT excluding unusual items
-2,00 მლნ.
-1,72 მლნ.
-3,18 მლნ.
-1,83 მლნ.
Income tax expense
-
-15,16 ათ.
-
-
Effective tax rate
-
0,88%
-
-
Other operating expenses
-
-
-
-
Net income
-2,00 მლნ.
-1,70 მლნ.
-3,18 მლნ.
-1,83 მლნ.
Net profit margin
-162,11%
-154,35%
-
-
Earnings per share
-0,12
-0,04
-0,16
-0,09
Interest and investment income
138,06 ათ.
165,63 ათ.
132,89 ათ.
112,56 ათ.
Interest expense
-
-
-
-
Net interest expenses
138,06 ათ.
165,63 ათ.
132,89 ათ.
112,56 ათ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google აპები